High Vista Strategies LLC Dyne Therapeutics, Inc. Transaction History
High Vista Strategies LLC
- $242 Million
- Q4 2024
A detailed history of High Vista Strategies LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 78,420 shares of DYN stock, worth $1.06 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
78,420
Previous 65,482
19.76%
Holding current value
$1.06 Million
Previous $2.35 Million
21.47%
% of portfolio
0.76%
Previous 0.92%
Shares
7 transactions
Others Institutions Holding DYN
# of Institutions
214Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$109 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$100 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$100 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$90.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$86.5 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $701M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...